These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 14982105)
1. Serotonin syndrome and the use of SSRIs. Finfgeld DL J Psychosoc Nurs Ment Health Serv; 2004 Feb; 42(2):16-20. PubMed ID: 14982105 [TBL] [Abstract][Full Text] [Related]
2. A surfeit of serotonin: sumatriptan and serotonergic antidepressants. Schwartz CE Arch Intern Med; 1999 May; 159(10):1141-2. PubMed ID: 10335694 [No Abstract] [Full Text] [Related]
3. Serotonin syndrome and rhabdomyolysis induced by concomitant use of triptans, fluoxetine and hypericum. Bonetto N; Santelli L; Battistin L; Cagnin A Cephalalgia; 2007 Dec; 27(12):1421-3. PubMed ID: 17868285 [No Abstract] [Full Text] [Related]
5. Co-administration of fluoxetine and sumatriptan: the Canadian experience. Joffe RT; Sokolov ST Acta Psychiatr Scand; 1997 Jun; 95(6):551-2. PubMed ID: 9242852 [TBL] [Abstract][Full Text] [Related]
6. Serotonin syndrome: a complex but easily avoidable condition. Dvir Y; Smallwood P Gen Hosp Psychiatry; 2008; 30(3):284-7. PubMed ID: 18433663 [TBL] [Abstract][Full Text] [Related]
7. A case report of serotonin syndrome associated with combined nefazodone and fluoxetine. Smith DL; Wenegrat BG J Clin Psychiatry; 2000 Feb; 61(2):146. PubMed ID: 10732666 [No Abstract] [Full Text] [Related]
8. Possible serotonin syndrome associated with buspirone added to fluoxetine. Manos GH Ann Pharmacother; 2000; 34(7-8):871-4. PubMed ID: 10928399 [TBL] [Abstract][Full Text] [Related]
9. The FDA alert on serotonin syndrome with use of triptans combined with selective serotonin reuptake inhibitors or selective serotonin-norepinephrine reuptake inhibitors: American Headache Society position paper. Evans RW; Tepper SJ; Shapiro RE; Sun-Edelstein C; Tietjen GE Headache; 2010 Jun; 50(6):1089-99. PubMed ID: 20618823 [TBL] [Abstract][Full Text] [Related]
10. Triptans and serotonin syndrome. Fine A; Bastings E Headache; 2012; 52(7):1184-5; author reply 1185-8. PubMed ID: 22755550 [No Abstract] [Full Text] [Related]
11. Possible serotonin syndrome with trazodone addition to fluoxetine. George TP; Godleski LS Biol Psychiatry; 1996 Mar; 39(5):384-5. PubMed ID: 8704074 [No Abstract] [Full Text] [Related]
14. From the editorial office. Rothrock JF Headache; 2012; 52(7):1069. PubMed ID: 22755549 [No Abstract] [Full Text] [Related]
15. Prevention, recognition, and management of serotonin syndrome. Ables AZ; Nagubilli R Am Fam Physician; 2010 May; 81(9):1139-42. PubMed ID: 20433130 [TBL] [Abstract][Full Text] [Related]
16. [Possible serotoninergic syndrome associated with coadministration of paroxetine and tramadol]. Llinares-Tello F; Escrivá-Moscardó S; Martínez-Pastor F; Martínez-Mascaraque P Med Clin (Barc); 2007 Mar; 128(11):438. PubMed ID: 17394862 [No Abstract] [Full Text] [Related]
17. Is an FDA alert harming patients? Schuman E JAAPA; 2009 May; 22(5):55. PubMed ID: 19469393 [No Abstract] [Full Text] [Related]
18. [Combination of serotonergic agents resulted in severe adverse effects]. Jägestedt M; von Bahr C Lakartidningen; 2004 Apr; 101(18):1618-9. PubMed ID: 15185539 [TBL] [Abstract][Full Text] [Related]
19. [Interaction between sumatriptan and selective serotonin uptake inhibitors]. Pomp E Tidsskr Nor Laegeforen; 1998 Aug; 118(18):2809-10. PubMed ID: 9748814 [TBL] [Abstract][Full Text] [Related]
20. Possible mild serotonin syndrome related to co-prescription of tandospirone and trazodone. Kaneda Y; Ohmori T; Okabe H Gen Hosp Psychiatry; 2001; 23(2):98-101. PubMed ID: 11354048 [No Abstract] [Full Text] [Related] [Next] [New Search]